Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

A randomised, multi-centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol.

Cornblath DR, Hartung HP, Katzberg HD, Merkies ISJ, van Doorn PA.

J Peripher Nerv Syst. 2018 Jun;23(2):108-114. doi: 10.1111/jns.12267. Epub 2018 Apr 26.

2.

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial.

van Schaik IN, Bril V, van Geloven N, Hartung HP, Lewis RA, Sobue G, Lawo JP, Praus M, Mielke O, Durn BL, Cornblath DR, Merkies ISJ; PATH study group.

Lancet Neurol. 2018 Jan;17(1):35-46. doi: 10.1016/S1474-4422(17)30378-2. Epub 2017 Nov 6. Erratum in: Lancet Neurol. 2018 Jan;17 (1):26. Lancet Neurol. 2018 Aug;17(8):661.

PMID:
29122523
3.

Protocol of a dose response trial of IV immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (DRIP study).

Kuitwaard K, Fokkink WR, Brusse E, Vrancken AFJE, Eftimov F, Notermans NC, van der Kooi AJ, Merkies ISJ, Jacobs BC, van Doorn PA.

J Peripher Nerv Syst. 2018 Mar;23(1):5-10. doi: 10.1111/jns.12244. Epub 2017 Nov 21.

PMID:
29119642
4.

Associated conditions in small fiber neuropathy - a large cohort study and review of the literature.

de Greef BTA, Hoeijmakers JGJ, Gorissen-Brouwers CML, Geerts M, Faber CG, Merkies ISJ.

Eur J Neurol. 2018 Feb;25(2):348-355. doi: 10.1111/ene.13508. Epub 2017 Dec 18.

5.

Maintenance IV immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy.

Kuitwaard K, Fokkink WR, Brusse E, Vrancken AFJE, Eftimov F, Notermans NC, van der Kooi AJ, Merkies ISJ, Jacobs BC, van Doorn PA.

J Peripher Nerv Syst. 2017 Dec;22(4):425-432. doi: 10.1111/jns.12242. Epub 2017 Nov 21. Review.

PMID:
29092099
6.

Quality of life in inflammatory neuropathies: the IN-QoL.

Draak THP, Faber CG, Merkies ISJ; PeriNomS study Group.

J Neurol Neurosurg Psychiatry. 2018 Mar;89(3):256-262. doi: 10.1136/jnnp-2017-316634. Epub 2017 Oct 6.

PMID:
28986470
7.

230th ENMC International Workshop:: Improving future assessment and research in IgM anti-MAG peripheral neuropathy: A consensus collaborative effort, Naarden, The Netherlands, 24-26 February 2017.

Pruppers MHJ, Merkies ISJ, Lunn MPT, Notermans NC; IMAGiNe Study Group.

Neuromuscul Disord. 2017 Nov;27(11):1065-1072. doi: 10.1016/j.nmd.2017.08.001. Epub 2017 Aug 2. No abstract available.

PMID:
28927829
8.

Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial.

Merkies ISJ, Lawo JP, Edelman JM, De Bleecker JL, Sommer C, Robberecht W, Saarela M, Kamienowski J, Stelmasiak Z, Mielke O, Tackenberg B, Léger JM; PRIMA trial investigators.

J Peripher Nerv Syst. 2017 Jun;22(2):149-152. doi: 10.1111/jns.12204. No abstract available.

9.

Network topology of NaV1.7 mutations in sodium channel-related painful disorders.

Kapetis D, Sassone J, Yang Y, Galbardi B, Xenakis MN, Westra RL, Szklarczyk R, Lindsey P, Faber CG, Gerrits M, Merkies IS, Dib-Hajj SD, Mantegazza M, Waxman SG, Lauria G; PROPANE Study Group.

BMC Syst Biol. 2017 Feb 24;11(1):28. doi: 10.1186/s12918-016-0382-0.

10.

COL6A5 variants in familial neuropathic chronic itch.

Martinelli-Boneschi F, Colombi M, Castori M, Devigili G, Eleopra R, Malik RA, Ritelli M, Zoppi N, Dordoni C, Sorosina M, Grammatico P, Fadavi H, Gerrits MM, Almomani R, Faber CG, Merkies IS, Toniolo D; INGI Network, Cocca M, Doglioni C, Waxman SG, Dib-Hajj SD, Taiana MM, Sassone J, Lombardi R, Cazzato D, Zauli A, Santoro S, Marchi M, Lauria G.

Brain. 2017 Mar 1;140(3):555-567. doi: 10.1093/brain/aww343.

PMID:
28073787
11.

A painful neuropathy-associated Nav1.7 mutant leads to time-dependent degeneration of small-diameter axons associated with intracellular Ca2+ dysregulation and decrease in ATP levels.

Rolyan H, Liu S, Hoeijmakers JG, Faber CG, Merkies IS, Lauria G, Black JA, Waxman SG.

Mol Pain. 2016 Nov 7;12. pii: 1744806916674472. Print 2016.

12.

Small Fiber Neuropathy in Children: Two Case Reports Illustrating the Importance of Recognition.

Hoeijmakers JG, Faber CG, Miedema CJ, Merkies IS, Vles JS.

Pediatrics. 2016 Oct;138(4). pii: e20161215.

13.

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.

van Schaik IN, van Geloven N, Bril V, Hartung HP, Lewis RA, Sobue G, Lawo JP, Mielke O, Cornblath DR, Merkies IS; PATH study group.

Trials. 2016 Jul 25;17(1):345. doi: 10.1186/s13063-016-1466-2.

14.

Intravenous immunoglobulin therapy for small fiber neuropathy: study protocol for a randomized controlled trial.

de Greef BT, Geerts M, Hoeijmakers JG, Faber CG, Merkies IS.

Trials. 2016 Jul 20;17(1):330. doi: 10.1186/s13063-016-1450-x.

15.
16.

Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathies.

Draak TH, Gorson KC, Vanhoutte EK, van Nes SI, van Doorn PA, Cornblath DR, van den Berg LH, Faber CG, Merkies IS; PeriNomS Study Group.

Eur J Neurol. 2016 Jul;23(7):1248-53. doi: 10.1111/ene.13025. Epub 2016 Apr 29.

PMID:
27129110
17.

Fatigue, Pain, Anxiety and Depression in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Merkies IS, Kieseier BC.

Eur Neurol. 2016;75(3-4):199-206. doi: 10.1159/000445347. Epub 2016 Apr 15.

18.

Does ability to walk reflect general functionality in inflammatory neuropathies?

Draak TH, Gorson KC, Vanhoutte EK, van Nes SI, van Doorn PA, Cornblath DR, van den Berg LH, Faber CG, Merkies IS; PeriNomS Study Group.

J Peripher Nerv Syst. 2016 Jun;21(2):74-81. doi: 10.1111/jns.12167.

PMID:
26968437
19.

No Fabry Disease in Patients Presenting with Isolated Small Fiber Neuropathy.

de Greef BT, Hoeijmakers JG, Wolters EE, Smeets HJ, van den Wijngaard A, Merkies IS, Faber CG, Gerrits MM.

PLoS One. 2016 Feb 11;11(2):e0148316. doi: 10.1371/journal.pone.0148316. eCollection 2016.

20.

Painful Diabetic Neuropathy Anxiety Rasch-Transformed Questionnaire (PART-Q30(©) ).

Geelen CC, Brouwer BA, Hoeijmakers JG, Faber CG, Merkies IS, Verbunt JA.

J Peripher Nerv Syst. 2016 Jun;21(2):96-104. doi: 10.1111/jns.12162.

PMID:
26840031
21.

Reconstructing the Rasch-Built Myotonic Dystrophy Type 1 Activity and Participation Scale.

Hermans MC, Hoeijmakers JG, Faber CG, Merkies IS.

PLoS One. 2015 Oct 20;10(10):e0139944. doi: 10.1371/journal.pone.0139944. eCollection 2015.

22.

Rasch-built Overall Disability Scale for Multifocal motor neuropathy (MMN-RODS(©) ).

Vanhoutte EK, Faber CG, van Nes SI, Cats EA, Van der Pol WL, Gorson KC, van Doorn PA, Cornblath DR, van den Berg LH, Merkies IS; PeriNomS Study Group.

J Peripher Nerv Syst. 2015 Sep;20(3):296-305. doi: 10.1111/jns.12141. Erratum in: J Peripher Nerv Syst. 2016 Mar;21(1):55.

PMID:
26329270
23.

Psychometric Properties of the Quantitative Myasthenia Gravis Score and the Myasthenia Gravis Composite Scale.

Barnett C, Merkies IS, Katzberg H, Bril V.

J Neuromuscul Dis. 2015 Sep 2;2(3):301-311.

24.

Epidermal innervation morphometry by immunofluorescence and bright-field microscopy.

Nolano M, Biasiotta A, Lombardi R, Provitera V, Stancanelli A, Caporaso G, Santoro L, Merkies IS, Truini A, Porretta-Serapiglia C, Cazzato D, Dacci P, Vitale DF, Lauria G.

J Peripher Nerv Syst. 2015 Dec;20(4):387-91. doi: 10.1111/jns.12146.

PMID:
26309146
25.

Rasch-Transformed Total Neuropathy Score clinical version (RT-TNSc(©) ) in patients with chemotherapy-induced peripheral neuropathy.

Binda D, Cavaletti G, Cornblath DR, Merkies IS; CI-PeriNomS study group.

J Peripher Nerv Syst. 2015 Sep;20(3):328-32. doi: 10.1111/jns.12140.

PMID:
26306547
26.

Recent advances in outcome measures in IgM-anti-MAG+ neuropathies.

Pruppers MH, Merkies IS, Notermans NC.

Curr Opin Neurol. 2015 Oct;28(5):486-93. doi: 10.1097/WCO.0000000000000236. Review.

PMID:
26263475
27.

Neuropathic Pain due to Small Fiber Neuropathy in Aging: Current Management and Future Prospects.

Brouwer BA, de Greef BT, Hoeijmakers JG, Geerts M, van Kleef M, Merkies IS, Faber CG.

Drugs Aging. 2015 Aug;32(8):611-21. doi: 10.1007/s40266-015-0283-8. Review.

28.

Ca2+ toxicity due to reverse Na+/Ca2+ exchange contributes to degeneration of neurites of DRG neurons induced by a neuropathy-associated Nav1.7 mutation.

Estacion M, Vohra BP, Liu S, Hoeijmakers J, Faber CG, Merkies IS, Lauria G, Black JA, Waxman SG.

J Neurophysiol. 2015 Sep;114(3):1554-64. doi: 10.1152/jn.00195.2015. Epub 2015 Jul 8.

29.

Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar.

Draak TH, Pruppers MH, van Nes SI, Vanhoutte EK, Bakkers M, Gorson KC, Van der Pol WL, Lewis RA, Notermans NC, Nobile-Orazio E, Léger JM, Van den Bergh PY, Lauria G, Bril V, Katzberg H, Lunn MP, Pouget J, van der Kooi AJ, van den Berg LH, van Doorn PA, Cornblath DR, Hahn AF, Faber CG, Merkies IS; PeriNomS study group.

J Peripher Nerv Syst. 2015 Sep;20(3):269-76. doi: 10.1111/jns.12126.

PMID:
26115516
30.

Outcome measures in MMN revisited: further improvement needed.

Pruppers MH, Draak TH, Vanhoutte EK, Van der Pol WL, Gorson KC, Léger JM, Nobile-Orazio E, Lewis RA, van den Berg LH, Faber CG, Merkies IS; PeriNomS study group.

J Peripher Nerv Syst. 2015 Sep;20(3):306-18. doi: 10.1111/jns.12124.

PMID:
26115442
31.

Rasch-ionale for neurologists.

Vanhoutte EK, Hermans MC, Faber CG, Gorson KC, Merkies IS, Thonnard JL; PeriNomS Study Group.

J Peripher Nerv Syst. 2015 Sep;20(3):260-8. doi: 10.1111/jns.12122. Review.

PMID:
26115370
32.

The Val30Met familial amyloid polyneuropathy specific Rasch-built overall disability scale (FAP-RODS(©) ).

Pruppers MH, Merkies IS, Faber CG, Da Silva AM, Costa V, Coelho T.

J Peripher Nerv Syst. 2015 Sep;20(3):319-27. doi: 10.1111/jns.12120.

PMID:
26115039
33.

Impairment measures versus inflammatory RODS in GBS and CIDP: a responsiveness comparison.

Vanhoutte EK, Draak TH, Gorson KC, van Nes SI, Hoeijmakers JG, Van der Pol WL, Notermans NC, Lewis RA, Nobile-Orazio E, Léger JM, Van den Bergh PY, Lauria G, Bril V, Katzberg H, Lunn MP, Pouget J, van der Kooi AJ, Hahn AF, van Doorn PA, Cornblath DR, van den Berg LH, Faber CG, Merkies IS; PeriNomS Study Group.

J Peripher Nerv Syst. 2015 Sep;20(3):289-95. doi: 10.1111/jns.12118.

PMID:
26114893
34.

Improving assessment in small fiber neuropathy.

Brouwer BA, Bakkers M, Hoeijmakers JG, Faber CG, Merkies IS.

J Peripher Nerv Syst. 2015 Sep;20(3):333-40. doi: 10.1111/jns.12128.

PMID:
26114213
35.

Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses.

Draak TH, Vanhoutte EK, van Nes SI, Gorson KC, Van der Pol WL, Notermans NC, Nobile-Orazio E, Lewis RA, Léger JM, Van den Bergh PY, Lauria G, Bril V, Katzberg H, Lunn MP, Pouget J, van der Kooi AJ, Hahn AF, van den Berg LH, van Doorn PA, Cornblath DR, Faber CG, Merkies IS; PeriNomS Study Group.

J Peripher Nerv Syst. 2015 Sep;20(3):277-88. doi: 10.1111/jns.12127.

PMID:
26110493
36.

Sodium channel Nav1.7 in vascular myocytes, endothelium, and innervating axons in human skin.

Rice FL, Albrecht PJ, Wymer JP, Black JA, Merkies IS, Faber CG, Waxman SG.

Mol Pain. 2015 May 9;11:26. doi: 10.1186/s12990-015-0024-3.

37.

The Domain II S4-S5 Linker in Nav1.9: A Missense Mutation Enhances Activation, Impairs Fast Inactivation, and Produces Human Painful Neuropathy.

Han C, Yang Y, de Greef BT, Hoeijmakers JG, Gerrits MM, Verhamme C, Qu J, Lauria G, Merkies IS, Faber CG, Dib-Hajj SD, Waxman SG.

Neuromolecular Med. 2015 Jun;17(2):158-69. doi: 10.1007/s12017-015-8347-9. Epub 2015 Mar 20.

PMID:
25791876
38.

Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with and without subsequent relapse.

Chin RL, Deng C, Bril V, Hartung HP, Merkies IS, Donofrio PD, Van Doorn PA, Dalakas MC, Latov N.

Muscle Nerve. 2015 Oct;52(4):498-502. doi: 10.1002/mus.24624. Epub 2015 Jul 24.

PMID:
25728021
39.

Peripheral neuropathies: Moving closer to mechanism.

Faber CG, Merkies IS.

Neurosci Lett. 2015 Jun 2;596:1-2. doi: 10.1016/j.neulet.2015.02.051. Epub 2015 Feb 24. No abstract available.

PMID:
25724276
40.

Advances in diagnostics and outcome measures in peripheral neuropathies.

Merkies IS, Faber CG, Lauria G.

Neurosci Lett. 2015 Jun 2;596:3-13. doi: 10.1016/j.neulet.2015.02.038. Epub 2015 Feb 19.

PMID:
25703220
41.

Painful peripheral neuropathy and sodium channel mutations.

Hoeijmakers JG, Faber CG, Merkies IS, Waxman SG.

Neurosci Lett. 2015 Jun 2;596:51-9. doi: 10.1016/j.neulet.2014.12.056. Epub 2014 Dec 31. Review.

PMID:
25556685
42.

Changing outcome in inflammatory neuropathies: Rasch-comparative responsiveness.

Draak TH, Vanhoutte EK, van Nes SI, Gorson KC, Van der Pol WL, Notermans NC, Nobile-Orazio E, Léger JM, Van den Bergh PY, Lauria G, Bril V, Katzberg H, Lunn MP, Pouget J, van der Kooi AJ, Hahn AF, Doorn PA, Cornblath DR, van den Berg LH, Faber CG, Merkies IS; PeriNomS Study Group.

Neurology. 2014 Dec 2;83(23):2124-32. doi: 10.1212/WNL.0000000000001044. Epub 2014 Nov 5.

PMID:
25378677
43.

Sodium channel genes in pain-related disorders: phenotype-genotype associations and recommendations for clinical use.

Waxman SG, Merkies ISJ, Gerrits MM, Dib-Hajj SD, Lauria G, Cox JJ, Wood JN, Woods CG, Drenth JPH, Faber CG.

Lancet Neurol. 2014 Nov;13(11):1152-1160. doi: 10.1016/S1474-4422(14)70150-4. Review.

PMID:
25316021
44.

Optimizing temperature threshold testing in small-fiber neuropathy.

Bakkers M, Faber CG, Reulen JP, Hoeijmakers JG, Vanhoutte EK, Merkies IS.

Muscle Nerve. 2015 Jun;51(6):870-6. doi: 10.1002/mus.24473. Epub 2015 Jan 10.

PMID:
25290248
45.

Contact heat evoked potentials: normal values and use in small-fiber neuropathy.

Lagerburg V, Bakkers M, Bouwhuis A, Hoeijmakers JG, Smit AM, Van Den Berg SJ, Hordijk-De Boer I, Brouwer-Van Der Lee MD, Kranendonk D, Reulen JP, Faber CG, Merkies IS.

Muscle Nerve. 2015 May;51(5):743-9. doi: 10.1002/mus.24465. Epub 2015 Mar 31.

PMID:
25256002
46.

Painful neuropathies: the emerging role of sodium channelopathies.

Brouwer BA, Merkies IS, Gerrits MM, Waxman SG, Hoeijmakers JG, Faber CG.

J Peripher Nerv Syst. 2014 Jun;19(2):53-65. doi: 10.1111/jns5.12071. Review.

PMID:
25250524
47.

The role of sodium channels in painful diabetic and idiopathic neuropathy.

Lauria G, Ziegler D, Malik R, Merkies IS, Waxman SG, Faber CG; PROPANE Study group.

Curr Diab Rep. 2014 Oct;14(10):538. doi: 10.1007/s11892-014-0538-5. Review.

PMID:
25142720
48.

Channelopathies, painful neuropathy, and diabetes: which way does the causal arrow point?

Hoeijmakers JG, Faber CG, Merkies IS, Waxman SG.

Trends Mol Med. 2014 Oct;20(10):544-50. doi: 10.1016/j.molmed.2014.06.003. Epub 2014 Jul 5.

PMID:
25008557
49.

Paroxysmal itch caused by gain-of-function Nav1.7 mutation.

Devigili G, Eleopra R, Pierro T, Lombardi R, Rinaldo S, Lettieri C, Faber CG, Merkies IS, Waxman SG, Lauria G.

Pain. 2014 Sep;155(9):1702-7. doi: 10.1016/j.pain.2014.05.006. Epub 2014 May 10.

PMID:
24820863
50.

Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study.

Griffith KA, Dorsey SG, Renn CL, Zhu S, Johantgen ME, Cornblath DR, Argyriou AA, Cavaletti G, Merkies IS, Alberti P, Postma TJ, Rossi E, Frigeni B, Bruna J, Velasco R, Kalofonos HP, Psimaras D, Ricard D, Pace A, Galie E, Briani C, Dalla Torre C, Faber CG, Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey DJ, Kerrigan S, Schenone A, Fabbri S, Valsecchi MG; CI-PeriNomS Group.

J Peripher Nerv Syst. 2014 Jun;19(2):127-35. doi: 10.1111/jns5.12064.

Supplemental Content

Loading ...
Support Center